Related Experiment Video

Updated: Aug 17, 2025

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

22.6K

Non-invasive vagus nerve stimulation modulates subthalamic beta activity in Parkinson's disease

Flavie Torrecillos1, Huiling Tan1, Peter Brown1

  • 1Medical Research Council Brain Network Dynamics Unit, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.

Brain Stimulation
|December 15, 2022
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Beta-burstsBrain sensingDeep brain stimulationFreezingLocal field potentialsVagus nerve stimulation

More Related Videos

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

28.7K
A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
07:14

A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test

Published on: May 31, 2016

14.8K

Related Experiment Videos

Last Updated: Aug 17, 2025

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

22.6K
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

28.7K
A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
07:14

A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test

Published on: May 31, 2016

14.8K

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

343
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
343
Neural Regulation01:37

Neural Regulation

39.7K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.7K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

650
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
650

Articles linked to this work by shared authors, journal, and citation graph.

Oligomeric Alpha-Synuclein from neural-derived extracellular vesicles as possible biomarkers of non-motor symptoms in Parkinson's disease.

NPJ Parkinson's disease·2026

Cognitive-behavioral therapy in people with Parkinson's disease and caregivers: A mixed method systematic review on clinical applications and therapeutic outcomes.

Journal of Parkinson's disease·2026

GLP-1 receptor agonists, metabolic syndrome, and Alzheimer's disease: Lessons and opportunities from the EVOKE trials.

Journal of neuroendocrinology·2026

Efficacy of citicoline as an add-on therapy in Parkinson's disease: a randomized, double-blind trial.

Parkinsonism & related disorders·2026

Overcoming acidic limitations: an Os-Ru bimetallic polymeric nanozyme at neutral pH for dual-mode detection of acetylcholinesterase activity and its inhibitors.

Journal of materials chemistry. B·2026

Bilateral transcutaneous auricular vagus nerve stimulation for misophonia symptoms: a case report and review of the literature.

Frontiers in psychology·2026

Noninvasive tFUS stimulation of the parabrachial nucleus suppresses lever pressing during extinction of cocaine self-administration through aversive circuit engagement.

Brain stimulation·2026

Perspectives of biophysical therapies in glioblastoma.

Brain stimulation·2026

A modular system for multichannel Transcranial Magnetic Stimulation: physical and physiological characterization of electric field profiles.

Brain stimulation·2026

Image-guided low-intensity focused ultrasound neuromodulation: acoustic targeting optimization and functional validation in a reward circuit model.

Brain stimulation·2026

E-field modeling of transcranial magnetic stimulation differentiates parietal contributions for grasping after stroke.

Brain stimulation·2026

Reduced left vmPFC-STN-related white matter integrity is associated with pre-surgical apathy in Parkinson's disease.

Brain stimulation·2026

[Comparison of peripheral neuropathy between Pola-R-CHP and R-CHOP: a retrospective analysis in an ambulatory therapy center].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

Inflammation in pregnancy and child neurodevelopment: A trio polygenic score and Mendelian randomization study in the Norwegian mother, father and child cohort.

Brain, behavior, and immunity·2026

Peripheral neuropathy after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and electrophysiologic features.

Transplantation and cellular therapy·2026

The PINK1-VCP-p47 pathway protects against tau-induced dendritic shrinkage in cortical neurons through interaction with STIP1.

Neurobiology of disease·2026

Neurotrophic effects of topical insulin in persistent epithelial defects.

International ophthalmology·2026

Vesicostomy in the Rat Model for Low-Pressure Urinary Drainage in Neurogenic Bladder Research.

Journal of visualized experiments : JoVE·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us